Elite Pharmaceuticals ELTP
OTC ELTP
$0.36 +0.04 (+12.34%)
As of: Nov 16, 2026 · 12:42 PM EST

Elite Pharmaceuticals (ELTP) Revenue (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) reported Revenue of $40.08 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 10.4% from $36.32 million a year earlier and up 23.9% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Revenue (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Elite Pharmaceuticals' Revenue came in at $144.77 million, up 17.8% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $148.87 million, up 77.1% from FY2025.

  • Revenue has increased for eight consecutive fiscal years, with a five-year compound annual growth rate of 42.4% (FY2021 to FY2026).
  • By fiscal year, Revenue came in at $84.04 million in FY2025 (+48.4%), $56.63 million in FY2024 (+65.8%), $34.16 million in FY2023 (+5.9%) and $32.26 million in FY2022 (+27.1%).
  • Five-year quarterly Revenue spans a low of $7.67 million in fiscal Q4 2022 and a high of $40.75 million in fiscal Q4 2026.
  • Year over year, Revenue gained in six of the last eight quarters, with growth averaging 51.9%.
  • The high point for year-over-year Revenue in five years was fiscal Q3 2026 (growth of 119.9%); the low point was fiscal Q1 2027 (a decline of 19.5%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $32.36 million (Q1 2027), $40.75 million (Q4 2026) and $31.59 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,289.17 Bn 1,262.79 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 686.41 Bn 606.27 Bn 17.30 Bn 25.40 Bn
3 AbbVie 524.44 Bn 492.45 Bn 13.12 Bn 17.40 Bn
4 Merck 361.49 Bn 324.43 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 313.73 Bn 286.97 Bn - -
6 Astrazeneca 287.01 Bn 260.53 Bn 13.26 Bn 15.07 Bn
7 Amgen 252.98 Bn 204.64 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 210.36 Bn 185.47 Bn 6.73 Bn 8.30 Bn
9 Pfizer 164.96 Bn 112.32 Bn 12.56 Bn 16.58 Bn
10 Elite Pharmaceuticals 387.23 Mn 260.64 Mn 15.99 Mn 40.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 40.08 Mn
Jun 30, 2026 32.36 Mn
Mar 31, 2026 40.75 Mn
Dec 31, 2025 31.59 Mn
Sep 30, 2025 36.32 Mn
Jun 30, 2025 40.21 Mn
Mar 31, 2025 32.00 Mn
Dec 31, 2024 14.36 Mn
Sep 30, 2024 18.88 Mn
Jun 30, 2024 18.80 Mn
Mar 31, 2024 17.95 Mn
Dec 31, 2023 15.54 Mn
Sep 30, 2023 14.16 Mn
Jun 30, 2023 8.98 Mn
Mar 31, 2023 8.64 Mn
Dec 31, 2022 9.25 Mn
Sep 30, 2022 8.59 Mn
Jun 30, 2022 7.67 Mn
Mar 31, 2022 7.67 Mn
Dec 31, 2021 8.97 Mn
API Access

Elite Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY